Certain Warrants of SAB Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 17-MAY-2026. These Warrants will be under lockup for 61 days starting from 17-MAR-2026 to 17-MAY-2026.

Details:
The executive officers and directors have agreed, with certain specified exceptions, not to engage in the following activities for a period of 60 days after the date of this prospectus supplement, without obtaining prior written consent from the representatives: They will not directly or indirectly sell, offer, contract, or grant any option to sell (including any short sale), pledge, transfer, or establish an open "put equivalent position" as defined by Rule 16a-1(h) under the Securities Exchange Act of 1934, as amended. They will not otherwise dispose of any shares of common stock, options, or warrants to acquire shares of common stock, or securities that are exchangeable, exercisable, or convertible into shares of common stock, whether currently owned or acquired in the future, either of record or beneficially. They will not publicly announce an intention to engage in any of the aforementioned activities.